Buy NantKwest Stock | NK Stock Price & Latest News | Public.com
NK

NantKwest

$0.00 (0.00%)Today
    View NantKwest (NK) stock trends here

    About NK

    NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headqua...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.07
    -0.14
    -0.21
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.21

    Actual EPS
    Q1 2021

    Stats

    Market Cap$3,09B
    Volume654,09k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$45.42
    1 Year Low$2.52
    Open$28.08
    High$28.65
    Low$26.17

    Buy any stock with any amount of money.

    Download the App
    Download the app